A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-α Antagonists

被引：0
|
作者：
Cassandra M. Townsend
Reena Khanna
Aze Suzanne Wilson
机构：
[1] Western University,Division of Gastroenterology, Department of Medicine
[2] Western University,Division of Clinical Pharmacology, Department of Medicine
[3] Western University,Department of Physiology and Pharmacology
来源：
Digestive Diseases and Sciences | 2021年 / 66卷
关键词：
Ulcerative colitis; Crohn’s disease; Inflammatory bowel disease; Tumor necrosis factor-; antagonists; Non-melanoma skin cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4436 / 4440
页数：4
相关论文
共 50 条
  • [11] Relationship Between Dose of Thiopurines and Development of Non-melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
    Trivedi, Chinmay
    Shah, Yash
    Khan, Nabeel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S422 - S422
  • [12] Non-Melanoma Skin Cancer in Patients with Inflammatory Bowel Disease: A Consequence of Anti-Metabolite Therapy?
    Blonski, Wojciech
    Buchner, Anna
    Weiner, Mark
    Marchioni, Renee
    Lin, Ming
    Lichtenstein, Gary
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S493 - S493
  • [13] The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines
    Bahi, Morwan
    Walmsley, Russell S.
    Gray, Andrew R.
    Young, David
    Hobbs, Catherine E.
    Aluzaite, Kristina
    Schultz, Michael
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (05) : 1047 - 1052
  • [14] Risk of Malignancy with Vedolizumab Versus Tumor Necrosis Factor-α Antagonists in Patients with Inflammatory Bowel Diseases
    Siddharth Singh
    Herbert C. Heien
    Lindsey Sangaralingham
    Nilay D. Shah
    William J. Sandborn
    Digestive Diseases and Sciences, 2022, 67 : 2510 - 2516
  • [15] Risk of Malignancy with Vedolizumab Versus Tumor Necrosis Factor-α Antagonists in Patients with Inflammatory Bowel Diseases
    Singh, Siddharth
    Heien, Herbert C.
    Sangaralingham, Lindsey
    Shah, Nilay D.
    Sandborn, William J.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (06) : 2510 - 2516
  • [16] Extramammary Paget disease: review of patients seen in a non-melanoma skin cancer clinic
    Pang, J.
    Assaad, D.
    Breen, D.
    Fialkov, J.
    Antonyshyn, O.
    Balogh, J.
    Tsao, M.
    Kamra, J.
    Czarnota, G.
    Barnes, E. A.
    CURRENT ONCOLOGY, 2010, 17 (05) : 230 - 232
  • [17] Association Between Tumor Necrosis Factor-α Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease (vol 311, pg 2406, 2014)
    Andersen, Nynne Nyboe
    Pasternak, Bjoern
    Basit, Saima
    Andersson, Mikael
    Svanstroem, Henrik
    Caspersen, Sarah
    Munkholm, Pia
    Hviid, Anders
    Jess, Tine
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (23): : A2406 - A2406
  • [18] Pustular Skin Reaction to Tumor Necrosis Factor Alpha Antagonists in Patients with Inflammatory Bowel Diseases
    Marzano, Angelo V.
    Tavecchio, Simona
    Berti, Emilio
    Gelmetti, Carlo
    Cugno, Massimo
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (11) : E26 - E27
  • [19] Optimizing Therapeutic Drug Monitoring of Tumor Necrosis Factor-α Antagonists in Patients With Inflammatory Bowel Diseases Reply
    Ben-Horin, Shomron
    Ungar, Bella
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (10) : 1509 - 1510
  • [20] Thiopurines and non-melanoma skin cancer: partners in crime in inflammatory bowel diseases
    Solitano, Virginia
    D'Amico, Ferdinando
    Correale, Carmen
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    BRITISH MEDICAL BULLETIN, 2020, 136 (01) : 107 - 117
12345